LIXTE BIOTECHNOLOGY HOLDINGS, INC. Quarterly Entity Common Stock, Shares Outstanding from Q2 2011 to Q3 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Lixte Biotechnology Holdings, Inc. quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q2 2011 to Q3 2024.
  • Lixte Biotechnology Holdings, Inc. Entity Common Stock, Shares Outstanding for the quarter ending November 1, 2024 was 2.25M shares, unchanged year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 2.25M 0 0% Nov 1, 2024 10-Q 2024-11-12
Q2 2024 2.25M 0 0% Aug 2, 2024 10-Q 2024-08-08
Q1 2024 2.25M -14.4M -86.5% Mar 1, 2024 10-K 2024-03-19
Q3 2023 2.25M -14.4M -86.5% Nov 6, 2023 10-Q 2023-11-09
Q2 2023 2.25M -14.4M -86.5% Aug 7, 2023 10-Q 2023-08-09
Q1 2023 16.7M +2.91M +21.2% Mar 10, 2023 10-K 2023-03-29
Q3 2022 16.6M +2.9M +21.1% Nov 1, 2022 10-Q 2022-11-08
Q2 2022 16.6M +2.9M +21.1% Aug 1, 2022 10-Q 2022-08-10
Q1 2022 13.7M +208K +1.54% Mar 11, 2022 10-K 2022-03-21
Q3 2021 13.7M -53.3M -79.5% Nov 1, 2021 10-Q 2021-11-10
Q2 2021 13.7M -53.3M -79.5% Aug 1, 2021 10-Q 2021-08-10
Q1 2021 13.5M -53.5M -79.8% Mar 12, 2021 10-K 2021-03-26
Q3 2020 67M 0 0% Nov 1, 2020 10-Q 2020-11-10
Q2 2020 67M 0 0% Aug 1, 2020 10-Q 2020-08-10
Q1 2020 67M 0 0% May 1, 2020 10-Q 2020-05-11
Q3 2019 67M +9M +15.5% Nov 1, 2019 10-Q 2019-11-08
Q2 2019 67M +9.02M +15.5% Aug 1, 2019 10-Q 2019-08-06
Q1 2019 67M +9.02M +15.5% Mar 1, 2019 10-K 2019-03-25
Q3 2018 58M +20K +0.03% Nov 1, 2018 10-Q 2018-11-08
Q2 2018 58M +150K +0.26% Aug 1, 2018 10-Q 2018-08-02
Q1 2018 58M +6.15M +11.9% Mar 1, 2018 10-K 2018-03-23
Q3 2017 58M +10.2M +21.2% Nov 1, 2017 10-Q 2017-11-09
Q2 2017 57.9M +10M +20.9% Aug 1, 2017 10-Q 2017-08-04
Q1 2017 51.9M +4M +8.36% Mar 10, 2017 10-K 2017-03-29
Q3 2016 47.9M 0 0% Nov 1, 2016 10-Q 2016-11-04
Q2 2016 47.9M +1M +2.13% Aug 1, 2016 10-Q 2016-08-10
Q1 2016 47.9M +2.3M +5.05% Apr 29, 2016 10-Q 2016-05-06
Q3 2015 47.9M +2.39M +5.26% Oct 31, 2015 10-Q 2015-11-10
Q2 2015 46.9M +1.39M +3.06% Jul 31, 2015 10-Q 2015-08-07
Q1 2015 45.6M +3.99M +9.6% Mar 20, 2015 10-K 2015-03-27
Q3 2014 45.5M +3.9M +9.38% Oct 31, 2014 10-Q 2014-11-12
Q2 2014 45.5M +3.9M +9.38% Jul 31, 2014 10-Q 2014-08-08
Q1 2014 41.6M 0 0% Mar 7, 2014 10-K 2014-03-21
Q3 2013 41.6M 0 0% Oct 31, 2013 10-Q 2013-11-07
Q2 2013 41.6M 0 0% Jul 31, 2013 10-Q 2013-08-05
Q1 2013 41.6M +6.22M +17.6% Mar 11, 2013 10-K 2013-03-15
Q3 2012 41.6M +6.32M +17.9% Oct 31, 2012 10-Q 2012-11-13
Q2 2012 41.6M +6.32M +17.9% Jul 31, 2012 10-Q 2012-08-10
Q1 2012 35.4M Mar 15, 2012 10-K 2012-03-29
Q3 2011 35.3M Nov 8, 2011 10-Q 2011-11-10
Q2 2011 35.3M Aug 11, 2011 10-Q 2011-08-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.